Back to Browse Journals » Patient Preference and Adherence » Volume 2

Adherence and persistence to typical and atypical antipsychotics in the naturalistic treatment of patients with schizophrenia

Authors Haya Ascher-Svanum, Baojin Zhu, Douglas E Faries, Jonathan P Lacro, Christian R Dolder, Xiaomei Peng

Published 13 March 2008 Volume 2008:2 Pages 67—77

DOI http://dx.doi.org/10.2147/PPA.S2940

Haya Ascher-Svanum1, Baojin Zhu1, Douglas E Faries1, Jonathan P Lacro2, Christian R Dolder3, Xiaomei Peng1

1Eli Lilly and Company, Outcomes Research, Indianapolis, IN, USA; 2VA San Diego Health Care System and Department of Psychiatry, University of California, San Diego, CA, USA; 3Wingate University School of Pharmacy, Wingate, NC, USA

Objective: To compare adherence and persistence to typical versus atypical antipsychotics and between specific atypical agents in the usual care of schizophrenia and to examine the association between adherence and persistence.

Method: Data were drawn from a 3-year prospective, nonrandomized, noninterventional study of schizophrenia conducted during 1997–2003. Initiators on haloperidol, risperidone, olanzapine, quetiapine, and clozapine with at least 1 year of follow-up were included (n = 878). Adherence (Medication Possession Ratio, MPR) and persistence (time to all-cause medication discontinuation) were assessed using medical record prescription information. Analyses employed multivariate statistics adjusted for group differences.

Results: Overall, 58% of the patients were deemed adherent (MPR >80%). Adherence rates were higher: for atypical (59.4%) than typical antipsychotics (34.5%, p < 0.001), for clozapine (77%) than each comparator excluding olanzapine (p < 0.01), and for olanzapine (64%) than risperidone (57%, p = 0.027) and quetiapine (52%, p = 0.019). Differences between risperidone and quetiapine were not statistically significant. Adherence and persistence were highly correlated (r = 0.957, p < 0.001).

Conclusion: In the usual care of schizophrenia, medication adherence and persistence appear to be highly correlated and to significantly differ between typical and atypical antipsychotics and among atypical agents. The choice of antipsychotic may play a meaningful role in patients’ adherence to and persistence with antipsychotic medications.

Keywords: adherence, persistence, schizophrenia, antipsychotics

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other articles by this author:

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia

Ascher-Svanum H, Brnabic AJM, Lawson AH, Kinon BJ, Stauffer VL, Feldman PD, Kelin K

Neuropsychiatric Disease and Treatment 2012, 8:113-118

Published Date: 15 March 2012

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

Xiaomei Peng, Haya Ascher-Svanum, Douglas Faries et al

ClinicoEconomics and Outcomes Research 2011, 3:9-14

Published Date: 11 January 2011

Readers of this article also read:

Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis

Lu M, Li J, Luo Z, Zhang S, Xue S, Wang K, Shi Y, Zhang C, Chen H, Li Z

OncoTargets and Therapy 2015, 8:1543-1552

Published Date: 22 June 2015

Central airways remodeling in COPD patients

Pini L, Pinelli V, Modina D, Bezzi M, Tiberio L, Tantucci C

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:927-933

Published Date: 1 September 2014

Delayed postural control during self-generated perturbations in the frail older adults

Kubicki A, Bonnetblanc F, Petrement G, Ballay Y, Mourey F

Clinical Interventions in Aging 2012, 7:65-75

Published Date: 29 February 2012

Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia

Hoeksema KA, Jayanthan A, Cooper T, Gore L, Trippett T, Boklan J, Arceci RJ, Narendran A

OncoTargets and Therapy 2011, 4:149-168

Published Date: 5 September 2011

Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis

Safaa Sebak, Maryam Mirzaei, Meenakshi Malhotra, et al

International Journal of Nanomedicine 2010, 5:525-532

Published Date: 15 September 2010

A highly sensitive and selective viral protein detection method based on RNA oligonucleotide nanoparticle

Changhyun Roh, Ho-Young Lee, Sang-Eun Kim, et al

International Journal of Nanomedicine 2010, 5:323-329

Published Date: 22 April 2010

Atomic force microscopy probing in the measurement of cell mechanics

Dimitrios Kirmizis, Stergios Logothetidis

International Journal of Nanomedicine 2010, 5:137-145

Published Date: 23 March 2010

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension

Peter Bramlage

Vascular Health and Risk Management 2009, 5:213-224

Published Date: 11 February 2009

Diabetes mellitus: a prothrombotic state. Implications for outcomes after coronary revascularization

Clarissa Cola, Salvatore Brugaletta, Victoria Martín Yuste, Bieito Campos, Dominick J Angiolillo, Manel Sabaté

Vascular Health and Risk Management 2009, 5:101-119

Published Date: 11 January 2009